By purchasing our forecast for GSK PLC (GSK) for the period of 5 days, you can gain valuable insights into the changes in value and dynamics of this stock. Specifically, our forecast will provide you with information on how the cost of GSK will change in December 2024, January 2025, February 2025, March 2025, and April 2025.
Having this information is highly beneficial for earning and diversifying your portfolio. With our forecast, you can make informed decisions on whether the cost of GSK will rise or fall during these months. This knowledge allows you to strategize effectively and choose the best course of action to maximize your returns.
Stay updated with our website for the release of new forecasts, ensuring that you are well-informed for the entire investment period. Take advantage of our forecasts to make intelligent investment choices and stay ahead in the market.
April 7, 2025QuantWave Achieves 7.44% Profit Target Forecast for GSK PLC ~1 min.On April 2, 2025, QuantWave, the automated forecasting platform, issued a short signal for GSK PLC stock with a price target forecast of $34.44, a 7.44% profit from the signal price of $37.21....
March 21, 2025GSK Lead Plaintiff Deadline Approaching - Contact Robbins LLP for Information About How to Lead the GSK PLC Class Action ~2 min.GSK PLC, a global pharmaceutical company, is facing a class action lawsuit....
March 19, 2025GSK Faces Class Action Lawsuit and Upcoming Deadlines - Investors Beware! ~2 min.Global pharmaceutical company, GSK PLC, is currently facing a class action lawsuit, with upcoming deadlines for affected investors to be aware of....
March 18, 2025QuantWave Successfully Achieves Price Target Forecast for GSK PLC, Generating 8.28% Profit ~2 min.On February 27, 2025, QuantWave, an automated forecasting platform, issued a long signal for GSK PLC with a price target forecast of $39.93. The stock was trading at $36.87 at the time of the signal....
March 15, 2025Shareholders that lost money on GSK plc GSK Urged to Join Class Action ~2 min.GSK plc, also known as GlaxoSmithKline, is facing a potential class action lawsuit from shareholders who have suffered financial losses....
March 14, 2025Glaxo GSK Up 8 Since Last Earnings Report: Can It Continue? ~2 min.GlaxoSmithKline (GSK) has been experiencing positive growth since its last earnings report, with stock prices soaring by 8%. This has left investors intrigued, wondering if this upward trend will continue....
March 7, 2025QuantWave Hits Bullseye with GSK PLC, Achieving 12.25% Profit Target ~2 min.QuantWave, the cutting-edge automated forecasting platform, has once again demonstrated its prowess in predicting stock movements with remarkable accuracy....
March 7, 2025QuantWave Successfully Hits Price Target Forecast for GSK PLC, Profiting 8.01% ~1 min.QuantWave, a leading automated forecasting platform, has achieved yet another successful price target forecast for the stock GSK PLC....
March 7, 2025QuantWave Achieves 10.6% Profit Target with GSK PLC Forecast ~1 min.QuantWave, the leading automated forecasting platform, recently hit a significant milestone with its price target forecast for GSK PLC....
March 7, 2025QuantWave Hits Target with GSK PLC Stock, Boasting 9.55% Profit ~1 min.QuantWave, a leading automated forecasting platform, has successfully met its price target forecast for GSK PLC stock, signaling a profitable long position....
February 28, 2025GSK plc Successfully Delivers on Pipeline Plans, Analysts Recommend Buying Stocks ~2 min.GSK plc, a leading pharmaceutical company, has recently impressed the market with its success in delivering on pipeline plans....
February 26, 2025GSK plc GSK: Analysts Recommend Buying Shares in Cheap Pharmaceutical Stocks ~1 min.GSK plc, a leading pharmaceutical company, has caught the attention of analysts as one of the top cheap stocks to invest in....
February 25, 2025GlaxoSmithKline (GSK) Enhances Pipeline Plans with Breakthrough Treatment - Stocks Prognosis ~3 min.GlaxoSmithKline, commonly known as GSK, a leading global pharmaceutical company, has recently made significant progress in its pipeline plans by developing a breakthrough treatment for a life-threatening disease. The company's innovative research and development efforts have paid off, leading to the creation of a promising drug that could potentially revolutionize the healthcare industry. GSK's br...
February 23, 2025GSK's Struggles in Convincing the Market about Pipeline Plans ~1 min.Pharmaceutical giant GSK PLC has been facing challenges in convincing the market that it can deliver on its ambitious pipeline plans....
February 21, 2025GSK PLC Earnings Report Exceeds Expectations, Stocks Prognosis Recommends Buying ~2 min.GSK PLC, a leading pharmaceutical company, has reported better-than-expected earnings for the latest quarter....
February 20, 2025GSK plc faces $300mn bet against it by Ken Griffin's Citadel ~1 min.GSK plc, the UK-based pharmaceutical company, is facing a significant challenge as Ken Griffin's Citadel has placed a $300mn bet against it....
February 19, 2025Subscribe to read Ken Griffins Citadel bets 300mn against drugmaker GSK ~2 min.GSK PLC, a leading pharmaceutical company, is facing a significant challenge as hedge fund manager Ken Griffin's Citadel has made a bold bet against the company....
February 18, 2025Ken Griffins Citadel bets 300mn against drugmaker GSK GSK plc ~2 min.GSK plc, one of the leading pharmaceutical companies worldwide, is facing a significant challenge as hedge fund Citadel has placed a massive bet against the drugmaker....
February 17, 2025Recent uptick might appease GSK plc LON:GSK institutional owners after losing 7.8% over the past year ~1 min.GSK plc, a leading pharmaceutical company, seems to be regaining its momentum with a recent uptick in its stock performance. Despite facing a 7....
February 14, 2025ROSEN RECOGNIZED INVESTOR COUNSEL Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action ~1 min.Pharmaceutical company GSK plc (LON:GSK) has recently faced a securities class action that may have significant implications for its investors....
| Stock ticker: | GSK |
| Name: | GSK PLC |
| Sector: | Healthcare |
| Investing Risk: | — |
| Forecast length: | — |
| Accuracy: | — |
| Average profit per target: | — |
| Signal Date | Signal Price ($) | Date Reached | Price Reached ($) | Profit (%) | Direction |
|---|---|---|---|---|---|
| 2023-11-28 | 33.53 | 2024-01-05 | 36.89 | 10.02 | long |
| 2023-12-05 | 34.18 | 2024-01-08 | 37.29 | 9.11 | long |
| 2023-12-12 | 34.26 | 2024-01-08 | 37.29 | 8.84 | long |
| 2023-12-19 | 34.34 | 2024-02-05 | 39.11 | 13.89 | long |
| 2023-12-26 | 34.82 | 2024-02-05 | 39.11 | 12.32 | long |
| 2024-01-02 | 35.29 | 2024-02-05 | 39.11 | 10.82 | long |
| 2024-01-09 | 37.4 | 2024-02-26 | 40.22 | 7.53 | long |
| 2024-01-23 | 36.95 | 2024-05-09 | 42.43 | 14.83 | long |
| 2024-01-30 | 36.77 | 2024-05-22 | 43.85 | 19.24 | long |
| 2024-07-30 | 38.09 | 2024-08-23 | 41.21 | 8.2 | long |
| 2024-08-06 | 37.05 | 2024-08-23 | 41.21 | 11.25 | long |
| 2024-08-13 | 39.44 | 2024-08-27 | 42.68 | 8.22 | long |
| 2024-10-15 | 37.67 | 2024-11-06 | 34.71 | 7.85 | short |
| 2024-12-10 | 34.43 | 2025-02-05 | 36.87 | 7.07 | long |
| 2024-12-11 | 33.69 | 2025-02-05 | 36.87 | 9.43 | long |
| 2025-02-11 | 35.27 | 2025-03-07 | 39.59 | 12.25 | long |
| 2025-02-18 | 35.8 | 2025-03-07 | 39.59 | 10.6 | long |
| 2025-02-20 | 36.14 | 2025-03-07 | 39.59 | 9.55 | long |
| 2025-02-24 | 36.66 | 2025-03-07 | 39.59 | 8.01 | long |
| 2025-02-27 | 36.87 | 2025-03-18 | 39.93 | 8.28 | long |
| 2025-04-02 | 37.21 | 2025-04-07 | 34.44 | 7.44 | short |
